MHRA announces corporate plan for 2023-2026 17 Jul 2023
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring a focus on patient access to innovation.
Its four central tenets are to:
- Maintain public trust through transparency and proactive communication
- Enable healthcare access to safe and effective medical products
- Deliver scientific and regulatory excellence through strategic partnerships
- Become an agency where people flourish alongside a responsive customer service culture.
Actions include a revised innovation pathway to accelerate new product approvals, launching a centralised knowledge hub as a single point of contact, along with public awareness initiatives to increase patients’ understanding of its decisions and public hearings on major safety issues.
For guidance on the changing landscape in medicines regulation in the UK, contact PMC via firstname.lastname@example.org or T: +44 (0) 208 168 1668.